Revolution Medicines

Manager, Legal Operations

North AmericaContract

process-improvement sharepoint stakeholder-management version-control

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Director, Senior Corporate Counsel, Spain

EuropeSenior

Spain

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

stakeholder-management

Director, Senior Corporate Counsel, Italy

Italy

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

stakeholder-management

Director, Senior Corporate Counsel, UKI

UKSenior

United Kingdom

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

stakeholder-management

North AmericaFull-timeSenior

Senior Clinical Data Manager

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

gcp sas

Senior Manager, Field Market Access, Spain

Spain

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Senior Oncology Account Manager, Switzerland

Switzerland

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

contract-negotiation performance-management process-improvement strategic-planning vendor-management

Associate Director, Congresses and Events, Midsized Markets

EuropeContract

Switzerland

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Product Manager, Germany

RemoteEurope

Germany

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Senior Product Manager, Germany

EuropeSenior

Germany

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

go-to-market

financial-reporting general-ledger performance-management stakeholder-management

Director, Finance, France

RemoteEurope

France

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Associate Director, Business Operations

North AmericaFull-time

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

smartsheet

networking regulatory-compliance

Senior Director, Regulatory Affairs, UKI

UKSenior

United Kingdom

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Senior Director, Regulatory Affairs, Italy

networking regulatory-compliance

Italy

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Director, Regulatory Affairs Companion Diagnostics (CDx)

North AmericaFull-time

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

Director, Regulatory Affairs Labelling, Europe

Europe

Switzerland

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

version-control

North AmericaContractSenior

Senior Clinical Program Manager

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

gcp smartsheet

North AmericaFull-timeSenior

Senior Manager, Commercial Manufacturing, Drug Substance

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to…

North AmericaFull-timeSenior

Senior Manager, Portfolio Management & Operations